Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Pulmonology · Alpha-1 Antitrypsin Deficiency

What is a Safe Indoor AQI Level for Alpha-1 (AATD)?

At a Glance

There is no universally safe AQI level for Alpha-1 Antitrypsin Deficiency (AATD), as standard guidelines do not protect highly vulnerable lungs. People with AATD should aim for indoor PM2.5 levels near zero by using HEPA filters, avoiding combustion appliances, and eliminating scented products.

There is no single universally “safe” Air Quality Index (AQI) level for individuals with Alpha-1 Antitrypsin Deficiency (AATD). Because people with AATD lack the protective protein that defends lung tissue against inflammation and oxidative stress [1][2], their lungs are exceptionally vulnerable to indoor air pollution [3]. Current regulatory guidelines—such as the standard EPA AQI—are designed for the general public and are widely considered insufficient for protecting patients with severe respiratory conditions like COPD or AATD [4][5]. In fact, research shows that adverse cardiorespiratory effects, lung function decline, and symptom flare-ups can occur even when air pollution concentrations fall below current regulatory thresholds [6][7][8].

For someone with AATD, even an outdoor AQI in the “Moderate” (Yellow) or high “Good” (Green) range can allow enough pollution indoors to trigger lung inflammation [9][10]. Therefore, optimizing your indoor air quality is a fundamental requirement for maintaining your respiratory health and preventing disease progression [11][12].

Specific Indoor Pollutants to Avoid

When managing AATD, you must be proactive about eliminating specific pollutants from your home environment. The most dangerous indoor pollutants for AATD include:

  • Particulate Matter (PM2.5): These microscopic particles often come from cooking, candles, or outdoor air seeping inside. High levels of PM2.5 are consistently linked to reduced lung function and a higher risk of acute COPD exacerbations—severe symptom flare-ups that can require hospitalization [13][14]. The World Health Organization (WHO) recommends keeping annual mean PM2.5 concentrations below 5 μg/m³ [15], though people with AATD should aim for levels as close to zero as possible.
  • Nitrogen Dioxide (NO2): Indoors, this gas is primarily produced by gas stoves, space heaters, and other combustion appliances. In individuals with COPD, short-term exposure to NO2 is associated with worsened respiratory symptoms, reduced lung function, and decreased oxygen saturation [16][17].
  • Volatile Organic Compounds (VOCs): These are airborne chemicals emitted by common household items like scented cleaning products, air fresheners, paints, and new furniture. Exposure to VOCs alters pulmonary immune cells and is independently associated with an increased risk of chronic bronchitis and emphysema [18][19].
  • Radon: An invisible, odorless radioactive gas that can accumulate in homes. Radon is a leading cause of lung cancer, and its presence can compound respiratory risks when combined with other indoor pollutants and underlying lung disease [20].

How to Interpret the AQI Scale with AATD

Standard AQI activity guidelines are not tailored to the unique vulnerability of AATD [10]. When reviewing the daily outdoor AQI:

  • Green (Good, 0-50): While considered safe for the general public, AATD patients may still be sensitive to the higher end of this range [8]. Monitor your symptoms closely. This is generally the best time to open windows to ventilate your home and clear out indoor pollutants.
  • Yellow (Moderate, 51-100): You belong to the “sensitive groups” category. At this level, consider limiting outdoor exertion and keeping windows closed to prevent outdoor pollutants from affecting your indoor air quality.
  • Orange (Unhealthy for Sensitive Groups, 101-150) and Above: Assume your indoor air will be impacted. Stay indoors, run high-efficiency air purifiers, and if you must go outside, use protective measures like a well-fitting N95, KN95, or FFP2 respirator mask to filter out dangerous particles [21].

Actionable Steps for Safer Indoor Air

To create the safest possible indoor environment for your lungs, focus on what you can control:

  • Use High-Performance Filtration: Running HEPA (High-Efficiency Particulate Air) purifiers in the rooms where you spend the most time has been shown to significantly reduce indoor concentrations of PM2.5 and associated pollutants [22][23]. If you have central air conditioning, upgrade your furnace filter to a MERV 13 or higher rating and change it regularly.
  • Mitigate Indoor Combustion: Avoid using wood-burning fireplaces, incense, and candles. If you have a gas stove and cannot afford to replace it with an electric or induction cooktop, always use an exhaust hood that vents directly to the outdoors while cooking. If you don’t have a vented hood, open a window (only if the outdoor AQI is safe) to disperse the NO2 emissions.
  • Switch Household Products: Remove scented aerosols, plug-in air fresheners, and harsh chemical cleaners from your home to minimize VOC exposure [18]. Opt for fragrance-free, asthma-and-allergy-friendly alternatives.
  • Test for Radon: Because radon is invisible and odorless, you cannot simply filter it out without knowing it’s there. Purchase a home radon testing kit or hire a professional service to ensure your home’s levels are safe [20].
  • Monitor Your Air: Consider purchasing an indoor air quality monitor to track your home’s PM2.5 levels. Use the monitor to verify that your HEPA filters are keeping PM2.5 levels below 5 μg/m³. Note that while consumer monitors are excellent for tracking PM2.5, they are generally less reliable for precise VOC measurements.

Common questions in this guide

What outdoor AQI is considered safe for someone with AATD?
Even an outdoor AQI in the "Moderate" or high "Good" range can trigger lung inflammation in people with AATD. You should monitor your symptoms closely even in the 0-50 range, and limit outdoor exertion when the AQI goes above 50.
Which indoor air pollutants are most dangerous for Alpha-1?
The most dangerous indoor pollutants include microscopic particulate matter (PM2.5), nitrogen dioxide (NO2) from gas appliances, volatile organic compounds (VOCs) from scented products, and radon gas. These can cause acute flare-ups and accelerate lung function decline.
How can I improve my indoor air quality if I have AATD?
You can improve your home's air quality by using HEPA air purifiers in the rooms where you spend the most time and upgrading your central air filter to MERV 13 or higher. Additionally, eliminate the use of wood-burning fires, candles, and scented household products.
Can I safely use a gas stove if I have Alpha-1 Antitrypsin Deficiency?
Gas stoves release nitrogen dioxide (NO2), which is linked to worsened respiratory symptoms and reduced lung function. If you cannot replace your gas stove, you should always use an exhaust hood that vents directly outdoors while cooking to disperse emissions.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific indoor air quality triggers should I prioritize eliminating based on my current lung function?
  2. 2.Given my specific AATD phenotype, at what outdoor AQI level should I avoid leaving the house?
  3. 3.Would you recommend a pulmonary rehabilitation program that includes guidance on optimizing my home environment?
  4. 4.Are there specific signs of an air-pollution-induced flare-up I should watch for that differ from a typical respiratory infection?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Oxidative Stress and Endoplasmic Reticulum Stress in Rare Respiratory Diseases.

    Magallón M, Pastor S, Carrión AE, et al.

    Journal of clinical medicine 2021; (10(6)) doi:10.3390/jcm10061268.

    PMID: 33803835
  2. 2

    [Alpha-1 antitrypsin deficiency].

    Dasí F

    Medicina clinica 2023; (160(5)):203-205 doi:10.1016/j.medcli.2022.09.001.

    PMID: 36253208
  3. 3

    Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency.

    Belchamber KBR, Walker EM, Stockley RA, Sapey E

    International journal of chronic obstructive pulmonary disease 2020; (15()):3183-3192 doi:10.2147/COPD.S276792.

    PMID: 33311976
  4. 4

    Estimating the number of cardio-pulmonary events potentially averted by fine particulate matter air quality index activity guidelines.

    Brook RD, Roa PA, Levy PD, et al.

    American journal of preventive cardiology 2025; (23()):101266 doi:10.1016/j.ajpc.2025.101266.

    PMID: 40978302
  5. 5

    Air pollution characteristics and health risks in Henan Province, China.

    Shen F, Ge X, Hu J, et al.

    Environmental research 2017; (156()):625-634 doi:10.1016/j.envres.2017.04.026.

    PMID: 28454015
  6. 6

    Hourly Air Pollutants and Acute Coronary Syndrome Onset in 1.29 Million Patients.

    Chen R, Jiang Y, Hu J, et al.

    Circulation 2022; (145(24)):1749-1760 doi:10.1161/CIRCULATIONAHA.121.057179.

    PMID: 35450432
  7. 7

    Short-term associations of low-level fine particulate matter (PM2.5) with cardiorespiratory hospitalizations in 139 Japanese cities.

    Hasegawa K, Tsukahara T, Nomiyama T

    Ecotoxicology and environmental safety 2023; (258()):114961 doi:10.1016/j.ecoenv.2023.114961.

    PMID: 37137261
  8. 8

    Impact of air quality guidelines on COPD sufferers.

    Liu Y, Yan S, Poh K, et al.

    International journal of chronic obstructive pulmonary disease 2016; (11()):839-72 doi:10.2147/COPD.S49378.

    PMID: 27143874
  9. 9

    Associations between daily air quality and hospitalisations for acute exacerbation of chronic obstructive pulmonary disease in Beijing, 2013-17: an ecological analysis.

    Liang L, Cai Y, Barratt B, et al.

    The Lancet. Planetary health 2019; (3(6)):e270-e279 doi:10.1016/S2542-5196(19)30085-3.

    PMID: 31229002
  10. 10

    Public Health Relevance of US EPA Air Quality Index Activity Recommendations.

    Brook RD, Rajagopalan S, Al-Kindi S

    JAMA network open 2024; (7(4)):e245292 doi:10.1001/jamanetworkopen.2024.5292.

    PMID: 38587845
  11. 11

    The Home-Based Rehabilitation of Patients Through Physical Exercises in the Context of Indoor Air Quality.

    Ilieș AB, Vlad S, Caciora T, et al.

    Healthcare (Basel, Switzerland) 2025; (13(13)) doi:10.3390/healthcare13131493.

    PMID: 40648520
  12. 12

    Critical review on emerging health effects associated with the indoor air quality and its sustainable management.

    Kumar P, Singh AB, Arora T, et al.

    The Science of the total environment 2023; (872()):162163 doi:10.1016/j.scitotenv.2023.162163.

    PMID: 36781134
  13. 13

    The impact of PM2.5 on lung function and chronic respiratory diseases: insights from genetic evidence.

    Feng B, Song J, Wang S, Chao L

    International journal of biometeorology 2024; (68(10)):2049-2054 doi:10.1007/s00484-024-02728-z.

    PMID: 38904841
  14. 14

    The Impact of Air Pollutants and Meteorological Factors on Chronic Obstructive Pulmonary Disease Exacerbations: A Nationwide Study.

    Huh JY, Hong J, Han DW, et al.

    Annals of the American Thoracic Society 2022; (19(2)):214-226 doi:10.1513/AnnalsATS.202103-298OC.

    PMID: 34499589
  15. 15

    COPD deaths attributable to ozone in 2019 and future projections using the WHO AQG 2021 in urban China.

    Yao M, Hu Y, Zhang A, et al.

    Eco-Environment & Health 2022; (1(4)):251-258 doi:10.1016/j.eehl.2022.11.002.

    PMID: 38077259
  16. 16

    Air pollution, weather and positive airway pressure treatment adherence in adults with sleep apnea: a retrospective community-based repeated-measures longitudinal study.

    Kendzerska T, Szyszkowicz M, Saymeh M, et al.

    Journal of sleep research 2024; (33(6)):e14183 doi:10.1111/jsr.14183.

    PMID: 38439127
  17. 17

    Air Pollution Exposure and Daily Lung Function in Chronic Obstructive Pulmonary Disease: Effect Modification by Eosinophil Level.

    Nurhussien L, Kang CM, Koutrakis P, et al.

    Annals of the American Thoracic Society 2022; (19(5)):728-736 doi:10.1513/AnnalsATS.202107-846OC.

    PMID: 34678126
  18. 18

    Combined association of urinary volatile organic compounds with chronic bronchitis and emphysema among adults in NHANES 2011-2014: The mediating role of inflammation.

    Wang Y, Yu Y, Zhang X, et al.

    Chemosphere 2024; (361()):141485 doi:10.1016/j.chemosphere.2024.141485.

    PMID: 38438022
  19. 19

    Interior Decorative VOCs Elevate T Cell-Mediated Obstructive Lung Disease Risks via Osteogenesis-Driven Lymphoid-Biased Hematopoiesis.

    Yu H, Zhang J, Liu Q, et al.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025; e12663 doi:10.1002/advs.202512663.

    PMID: 41190786
  20. 20

    Indoor air pollutants, ventilation rate determinants and potential control strategies in Chinese dwellings: A literature review.

    Ye W, Zhang X, Gao J, et al.

    The Science of the total environment 2017; (586()):696-729 doi:10.1016/j.scitotenv.2017.02.047.

    PMID: 28215812
  21. 21

    Air pollution and chronic airway diseases: what should people know and do?

    Jiang XQ, Mei XD, Feng D

    Journal of thoracic disease 2016; (8(1)):E31-40 doi:10.3978/j.issn.2072-1439.2015.11.50.

    PMID: 26904251
  22. 22

    The Impact of Four-Stage Air Filtration Systems on the Well-Being of Residents Living in Skilled Nursing Care Facilities.

    Arias-Guzman S, Anastasova-Mikic Z, Jellum S, et al.

    HERD 2025; (18(4)):199-209 doi:10.1177/19375867251353736.

    PMID: 40653788
  23. 23

    Control of wildfire-sourced PM2.5 in an office setting using a commercially available portable air cleaner.

    Stauffer DA, Autenrieth DA, Hart JF, Capoccia S

    Journal of occupational and environmental hygiene 2020; (17(4)):109-120 doi:10.1080/15459624.2020.1722314.

    PMID: 32160140

This page provides educational information on indoor air quality management for AATD. It does not replace professional medical advice. Always consult your pulmonologist about your specific environmental triggers and respiratory care.

Get notified when new evidence is published on Alpha-1-antitrypsin deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.